MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

37.34 -0.11

Buy Sell

Overview

Share price change

24h

Current

Min

36.93

Max

37.47

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	11.959 88.032
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+16.64% upside

Market Stats
By TradingEconomics
Market Cap	496M 2.2B
Previous open	37.45
Previous close	37.34

News Sentiment

By Acuity

50%

142 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 sty 2026, 22:45 UTC

Major Market Movers

GH Research Shares Up, Plans to Provide Update on New Drug Application

4 sty 2026, 23:50 UTC

Market Talk

Major News Events

Gold Rises Amid Geopolitical Risks After Maduro's Ouster -- Market Talk

4 sty 2026, 23:50 UTC

Market Talk

Major News Events

Nikkei May Decline After Removal of Venezuela's Maduro -- Market Talk

4 sty 2026, 23:41 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

4 sty 2026, 23:40 UTC

Market Talk

Major News Events

Markets Mostly Calm as Venezuelan Raid Weighed -- Market Talk

4 sty 2026, 23:35 UTC

Market Talk

Major News Events

Oil Declines on Oversupply Worries After Maduro's Ouster -- Market Talk

4 sty 2026, 23:19 UTC

Market Talk

Major News Events

Global Energy Roundup: Market Talk

4 sty 2026, 23:19 UTC

Market Talk

Major News Events

ONGC Could Receive $500M in Unpaid Dividends From U.S. Takeover of Venezuelan Oil -- Market Talk

4 sty 2026, 23:17 UTC

Major News Events

Spot Gold Rises 0.8% to $4,365.24/oz

4 sty 2026, 23:16 UTC

Major News Events

Spot Gold Rises After U.S.' Removal of Venezuela's Maduro

4 sty 2026, 23:14 UTC

Major News Events

Front-Month WTI Crude Oil Futures Fall 0.6%; Front-Month Brent Crude Oil Futures Drop 0.5%

4 sty 2026, 23:13 UTC

Major News Events

Front-Month Crude Oil Futures Fall After Ouster of Venezuela's Maduro

4 sty 2026, 23:12 UTC

Market Talk

Major News Events

Reliance Industries' Could Benefit from U.S. Takeover of Venezuelan Oil -- Market Talk

4 sty 2026, 22:37 UTC

Market Talk

Major News Events

Gold Can Gain From Flight to Quality, Central Bank Demand After Maduro Ouster -- Market Talk

4 sty 2026, 21:00 UTC

Earnings

An On-Time Jobs Report. Plus, Albertsons, Constellation, Jefferies, and More Stocks to Watch this Week. -- Barrons.com

4 sty 2026, 20:49 UTC

Market Talk

Major News Events

Global Energy Roundup: Market Talk

4 sty 2026, 20:49 UTC

Market Talk

Major News Events

Jitters About Potential for U.S. Actions Elsewhere Could Grow -- Market Talk

3 sty 2026, 18:59 UTC

Major News Events

Update: Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 sty 2026, 17:42 UTC

Major News Events

The Oil Sector's Biggest Winners and Losers From Venezuela Regime Change -- Barrons.com

3 sty 2026, 17:40 UTC

Major News Events

Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 sty 2026, 16:10 UTC

Major News Events

What Maduro's Capture Means for Chevron Stock -- Barrons.com

3 sty 2026, 15:53 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 sty 2026, 15:03 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 sty 2026, 14:10 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 sty 2026, 12:16 UTC

Major News Events

U.S. Captures Maduro, Trump Says -- Barrons.com

3 sty 2026, 09:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

3 sty 2026, 09:20 UTC

Market Talk

Earnings

Auto & Transport Roundup: Market Talk

3 sty 2026, 00:43 UTC

Acquisitions, Mergers, Takeovers

Research Reports -- Barrons.com

2 sty 2026, 22:13 UTC

Market Talk

Earnings

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2 sty 2026, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

16.64% upside

12 Months Forecast

Average 43.6 USD 16.64%

High 55 USD

Low 32 USD

Based on 6 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

142 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.